Cyclo Therapeutics Correlations

CYTH Stock

USD 0.73 0.03 4.29%

The correlation of Cyclo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Cyclo Therapeutics Correlation With Market

Good diversification

The correlation between Cyclo Therapeutics and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Cyclo Stock please use our How to Invest in Cyclo Therapeutics guide.

Moving against Cyclo Stock

0.44	NXGLW	NexGel Warrant	Pair Corr
0.38	RNXT	RenovoRx	Pair Corr
0.34	PG	Procter Gamble	Pair Corr
0.34	T	ATT Inc Aggressive Push	Pair Corr

Related Correlations Analysis

	ATNX	MMNFF	LFCR	LSDI	GHSI	AGRX	TKNO	PTPI	PAHC	SHMN
ATNX		-0.88	-0.41	0.94	-0.5	0.95	-0.65	0.29	-0.78	0.43	ATNX
MMNFF	-0.88		0.42	-0.94	0.61	-0.87	0.69	-0.32	0.72	-0.58	MMNFF
LFCR	-0.41	0.42		-0.39	-0.08	-0.51	0.69	-0.52	0.54	-0.58	LFCR
LSDI	0.94	-0.94	-0.39		-0.57	0.94	-0.64	0.3	-0.75	0.46	LSDI
GHSI	-0.5	0.61	-0.08	-0.57		-0.55	0.46	0.3	0.4	-0.24	GHSI
AGRX	0.95	-0.87	-0.51	0.94	-0.55		-0.74	0.28	-0.82	0.41	AGRX
TKNO	-0.65	0.69	0.69	-0.64	0.46	-0.74		-0.32	0.76	-0.58	TKNO
PTPI	0.29	-0.32	-0.52	0.3	0.3	0.28	-0.32		-0.38	0.43	PTPI
PAHC	-0.78	0.72	0.54	-0.75	0.4	-0.82	0.76	-0.38		-0.45	PAHC
SHMN	0.43	-0.58	-0.58	0.46	-0.24	0.41	-0.58	0.43	-0.45		SHMN
	ATNX	MMNFF	LFCR	LSDI	GHSI	AGRX	TKNO	PTPI	PAHC	SHMN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AGRX	+ 0.95	ATNX
LSDI	+ 0.94	ATNX
AGRX	+ 0.94	LSDI
PAHC	+ 0.76	TKNO
PAHC	+ 0.72	MMNFF
TKNO	+ 0.69	MMNFF

High negative correlations

LSDI	- 0.94	MMNFF
MMNFF	- 0.88	ATNX
AGRX	- 0.87	MMNFF
PAHC	- 0.82	AGRX
PAHC	- 0.78	ATNX
PAHC	- 0.75	LSDI

Risk-Adjusted Indicators

There is a big difference between Cyclo Stock performing well and Cyclo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cyclo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ATNX	13.35	(3.60)	0.00	1.39	0.00	0.00	25.00	(35.00)	143.13
MMNFF	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
LFCR	4.14	0.38	0.06	0.38	6.50	(4.14)	9.76	(6.68)	30.90
LSDI	298.43	147.97	3.23	5.56	27.98	(972.40)	550.00	(81.82)	3,998
GHSI	5.47	0.68	0.06	(6.47)	8.11	(7.10)	18.66	(7.94)	101.05
AGRX	3.20	(1.09)	0.00	2.42	0.00	0.00	7.63	(7.16)	19.82
TKNO	4.64	0.57	0.12	0.44	5.10	(5.15)	12.84	(8.91)	32.06
PTPI	3.85	(0.17)	0.00	0.43	0.00	0.00	6.25	(7.89)	45.54
PAHC	1.96	0.16	0.13	0.21	1.62	(2.30)	5.36	(2.45)	15.47
SHMN	5.27	(0.39)	0.00	(6.31)	0.00	0.00	11.11	(11.11)	38.18

Cyclo Therapeutics Corporate Management

Michael Lisjak	Global Development	Profile
Lise MD	Chief Officer	Profile
George Fails	Ex Mang	Profile
Jeffrey Tate	Chief COO	Profile
Scott Fine	CEO Director	Profile
Lori McKenna	Global Advocacy	Profile
E Strattan	Founder Director	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC